I am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account @aayushipratap
Merck and its partner Ridgeback Biotherapeutics have developed an antiviral pill that helps reduce hospitalizations and deaths in patients with mild Covid-19Covid-19 cases were already beginning to surge around the world before scientists in South Africa identified the omicron variant.
Before selling the pills in India, pharma companies are required to conduct trials based on protocols laid out by the Central Drugs Controller General of India, a government body in charge of approving investigational drugs. Several of the manufacturers spoke to Forbes about their status. Indian pharmaceutical giant Dr Reddy’s Laboratories collaborated with Cipla Limited, Emcure Pharmaceuticals, Sun Pharmaceutical and Torrent Pharmaceuticals to conduct clinical trials with molnupiravir. The companies did not respond to a request for comment on trial results or the status of their manufacturing operations.
Indian pharma companies who have license agreements with Merck are undeterred by the reduced efficacy data. “It's like running a marathon, and you are still in the first 500 meters. Who is going to win, no one knows,” says Dani of Aurobindo Pharmaceutical. “The point is not what is superior or inferior. The fact that the pill works itself is great news,” he added.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Indian man beaten to death inside historic Sikh temple | AP NewsNEW DELHI (AP) — A man was beaten to death in the northern Indian city of Amritsar after he allegedly attempted to commit a sacrilegious act inside the historic Golden Temple, one of Sikhs' most revered shrines.
Weiterlesen »
An economic history of restaurantsCovid brought to a halt an astonishing expansion in the restaurant business
Weiterlesen »
Covid: Civil servant quits party probe and footballers urged to get Covid jabFive things you need to know about the coronavirus pandemic this Saturday morning.
Weiterlesen »
Covid-19: Nisra records increase in Covid-related deathsThe agency's Covid deaths total, based on mentions of the virus on death certificates, is 3,937.
Weiterlesen »
Vegas NYE Parties Rage on Despite COVID Omicron SurgeThe Las Vegas Strip will be party central for NYE and bringing in 2022, despite COVID surge.
Weiterlesen »